 | • レポートコード：GIR-22F19190 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Botulinum Toxins in Dermatology and Cosmetology Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の皮膚科学及び美容学におけるボツリヌス毒素の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 皮膚科学及び美容学におけるボツリヌス毒素市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・医療、化粧品 アプリケーション別セグメントは次のように区分されます。 ・病院、美容院 世界の皮膚科学及び美容学におけるボツリヌス毒素市場の主要な市場プレーヤーは以下のとおりです。 ・Allergan、Ipsen、Medytox、LIBP、Merz Pharmaceuticals、US World Meds、Hugel、Daewoong 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、皮膚科学及び美容学におけるボツリヌス毒素製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な皮膚科学及び美容学におけるボツリヌス毒素メーカーの企業概要、2019年～2022年までの皮膚科学及び美容学におけるボツリヌス毒素の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な皮膚科学及び美容学におけるボツリヌス毒素メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別皮膚科学及び美容学におけるボツリヌス毒素の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの皮膚科学及び美容学におけるボツリヌス毒素のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での皮膚科学及び美容学におけるボツリヌス毒素市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および皮膚科学及び美容学におけるボツリヌス毒素の産業チェーンを掲載しています。 ・第13、14、15章では、皮膚科学及び美容学におけるボツリヌス毒素の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 皮膚科学及び美容学におけるボツリヌス毒素の概要 - タイプ別分析（2017年vs2021年vs2028年）：医療、化粧品 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、美容院 - 世界の皮膚科学及び美容学におけるボツリヌス毒素市場規模・予測 - 世界の皮膚科学及び美容学におけるボツリヌス毒素生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Allergan、Ipsen、Medytox、LIBP、Merz Pharmaceuticals、US World Meds、Hugel、Daewoong ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：医療、化粧品 ・アプリケーション別分析2017年-2028年：病院、美容院 ・皮膚科学及び美容学におけるボツリヌス毒素の北米市場分析 - 皮膚科学及び美容学におけるボツリヌス毒素の北米市場：タイプ別市場規模2017年-2028年 - 皮膚科学及び美容学におけるボツリヌス毒素の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・皮膚科学及び美容学におけるボツリヌス毒素のヨーロッパ市場分析 - ：皮膚科学及び美容学におけるボツリヌス毒素のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：皮膚科学及び美容学におけるボツリヌス毒素のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・皮膚科学及び美容学におけるボツリヌス毒素のアジア太平洋市場分析 - 皮膚科学及び美容学におけるボツリヌス毒素のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 皮膚科学及び美容学におけるボツリヌス毒素のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・皮膚科学及び美容学におけるボツリヌス毒素の南米市場分析 - 皮膚科学及び美容学におけるボツリヌス毒素の南米市場：タイプ別市場規模2017年-2028年 - 皮膚科学及び美容学におけるボツリヌス毒素の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・皮膚科学及び美容学におけるボツリヌス毒素の中東・アフリカ市場分析 - 皮膚科学及び美容学におけるボツリヌス毒素の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 皮膚科学及び美容学におけるボツリヌス毒素の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Botulinum Toxins in Dermatology and Cosmetology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Botulinum Toxins in Dermatology and Cosmetology market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Botulinum Toxins in Dermatology and Cosmetology global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Medical segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Botulinum Toxins in Dermatology and Cosmetology include Allergan, Ipsen, Medytox, LIBP, and Merz Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Botulinum Toxins in Dermatology and Cosmetology market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Medical
Cosmetic
Market segment by Application can be divided into
Hospital
Beauty Salon
The key market players for global Botulinum Toxins in Dermatology and Cosmetology market are listed below:
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Botulinum Toxins in Dermatology and Cosmetology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Botulinum Toxins in Dermatology and Cosmetology, with price, sales, revenue and global market share of Botulinum Toxins in Dermatology and Cosmetology from 2019 to 2022.
Chapter 3, the Botulinum Toxins in Dermatology and Cosmetology competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Botulinum Toxins in Dermatology and Cosmetology breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Botulinum Toxins in Dermatology and Cosmetology market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Botulinum Toxins in Dermatology and Cosmetology.
Chapter 13, 14, and 15, to describe Botulinum Toxins in Dermatology and Cosmetology sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Botulinum Toxins in Dermatology and Cosmetology Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Medical
1.2.3 Cosmetic
1.3 Market Analysis by Application
1.3.1 Overview: Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Beauty Salon
1.4 Global Botulinum Toxins in Dermatology and Cosmetology Market Size & Forecast
1.4.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Botulinum Toxins in Dermatology and Cosmetology Sales in Volume (2017-2028)
1.4.3 Global Botulinum Toxins in Dermatology and Cosmetology Price (2017-2028)
1.5 Global Botulinum Toxins in Dermatology and Cosmetology Production Capacity Analysis
1.5.1 Global Botulinum Toxins in Dermatology and Cosmetology Total Production Capacity (2017-2028)
1.5.2 Global Botulinum Toxins in Dermatology and Cosmetology Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Botulinum Toxins in Dermatology and Cosmetology Market Drivers
1.6.2 Botulinum Toxins in Dermatology and Cosmetology Market Restraints
1.6.3 Botulinum Toxins in Dermatology and Cosmetology Trends Analysis
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Botulinum Toxins in Dermatology and Cosmetology Product and Services
2.1.4 Allergan Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ipsen
2.2.1 Ipsen Details
2.2.2 Ipsen Major Business
2.2.3 Ipsen Botulinum Toxins in Dermatology and Cosmetology Product and Services
2.2.4 Ipsen Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Medytox
2.3.1 Medytox Details
2.3.2 Medytox Major Business
2.3.3 Medytox Botulinum Toxins in Dermatology and Cosmetology Product and Services
2.3.4 Medytox Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 LIBP
2.4.1 LIBP Details
2.4.2 LIBP Major Business
2.4.3 LIBP Botulinum Toxins in Dermatology and Cosmetology Product and Services
2.4.4 LIBP Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merz Pharmaceuticals
2.5.1 Merz Pharmaceuticals Details
2.5.2 Merz Pharmaceuticals Major Business
2.5.3 Merz Pharmaceuticals Botulinum Toxins in Dermatology and Cosmetology Product and Services
2.5.4 Merz Pharmaceuticals Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 US World Meds
2.6.1 US World Meds Details
2.6.2 US World Meds Major Business
2.6.3 US World Meds Botulinum Toxins in Dermatology and Cosmetology Product and Services
2.6.4 US World Meds Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hugel
2.7.1 Hugel Details
2.7.2 Hugel Major Business
2.7.3 Hugel Botulinum Toxins in Dermatology and Cosmetology Product and Services
2.7.4 Hugel Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Daewoong
2.8.1 Daewoong Details
2.8.2 Daewoong Major Business
2.8.3 Daewoong Botulinum Toxins in Dermatology and Cosmetology Product and Services
2.8.4 Daewoong Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Botulinum Toxins in Dermatology and Cosmetology Breakdown Data by Manufacturer
3.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Botulinum Toxins in Dermatology and Cosmetology
3.4 Market Concentration Rate
3.4.1 Top 3 Botulinum Toxins in Dermatology and Cosmetology Manufacturer Market Share in 2021
3.4.2 Top 6 Botulinum Toxins in Dermatology and Cosmetology Manufacturer Market Share in 2021
3.5 Global Botulinum Toxins in Dermatology and Cosmetology Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Botulinum Toxins in Dermatology and Cosmetology Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Botulinum Toxins in Dermatology and Cosmetology Market Size by Region
4.1.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales in Volume by Region (2017-2028)
4.1.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2017-2028)
4.2 North America Botulinum Toxins in Dermatology and Cosmetology Revenue (2017-2028)
4.3 Europe Botulinum Toxins in Dermatology and Cosmetology Revenue (2017-2028)
4.4 Asia-Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue (2017-2028)
4.5 South America Botulinum Toxins in Dermatology and Cosmetology Revenue (2017-2028)
4.6 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales in Volume by Type (2017-2028)
5.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2017-2028)
5.3 Global Botulinum Toxins in Dermatology and Cosmetology Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales in Volume by Application (2017-2028)
6.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2017-2028)
6.3 Global Botulinum Toxins in Dermatology and Cosmetology Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
7.2 North America Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
7.3 North America Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
7.3.1 North America Botulinum Toxins in Dermatology and Cosmetology Sales in Volume by Country (2017-2028)
7.3.2 North America Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
8.2 Europe Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
8.3 Europe Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
8.3.1 Europe Botulinum Toxins in Dermatology and Cosmetology Sales in Volume by Country (2017-2028)
8.3.2 Europe Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
9.2 Asia-Pacific Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
9.3 Asia-Pacific Botulinum Toxins in Dermatology and Cosmetology Market Size by Region
9.3.1 Asia-Pacific Botulinum Toxins in Dermatology and Cosmetology Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
10.2 South America Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
10.3 South America Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
10.3.1 South America Botulinum Toxins in Dermatology and Cosmetology Sales in Volume by Country (2017-2028)
10.3.2 South America Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
11.2 Middle East & Africa Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
11.3 Middle East & Africa Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
11.3.1 Middle East & Africa Botulinum Toxins in Dermatology and Cosmetology Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Botulinum Toxins in Dermatology and Cosmetology and Key Manufacturers
12.2 Manufacturing Costs Percentage of Botulinum Toxins in Dermatology and Cosmetology
12.3 Botulinum Toxins in Dermatology and Cosmetology Production Process
12.4 Botulinum Toxins in Dermatology and Cosmetology Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Botulinum Toxins in Dermatology and Cosmetology Typical Distributors
13.3 Botulinum Toxins in Dermatology and Cosmetology Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer